Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than answers about the future of cancer vaccines.
November 13, 2026 ※L'Arc-en-Ciel fan(Nekota)🐱ྀི It's the usual BMSG crowd for Kohaku again this year. As for the former ...
A new frontier of in vivo cell engineering To gain a more comprehensive understanding of the heterogeneity among CD4 T cells ...
National Vision Holdings, Inc. ( EYE) Q3 2026 Earnings Call November 12, 2026 8:30 AM EST ...
Dogecoin explained: the technology, merged mining with Litecoin, why around 5 billion new DOGE are added each year and what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results